Valuation: Medistim ASA

Market Cap 4.98B 521M 463M 433M 393M 735M 50.2B 746M 5.2B 2.02B 25.63B 1.96B 1.91B 82.16B P/E 2026 *
27.2x
P/E 2027 * 25.1x
Enterprise Value 4.84B 507M 450M 421M 382M 715M 48.81B 726M 5.06B 1.97B 24.92B 1.9B 1.86B 79.89B EV / Sales 2026 *
6.06x
EV / Sales 2027 * 5.55x
Free-Float
79.47%
Yield 2026 *
3.17%
Yield 2027 * 3.29%
1 day+5.02%
1 week+8.37%
Current month+7.51%
1 month+8.80%
3 months+19.30%
6 months+27.10%
Current year+5.02%
1 week 250
Extreme 250
273
1 month 240
Extreme 240
273
Current year 186.5
Extreme 186.5
273
1 year 186.5
Extreme 186.5
292
3 years 130
Extreme 130
292
5 years 130
Extreme 130
402.5
10 years 60
Extreme 60
409
Manager TitleAgeSince
Chief Executive Officer 62 01/09/2009
Director of Finance/CFO - 01/01/2001
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Chairman 78 01/01/2000
Director/Board Member 49 01/01/2014
Director/Board Member 56 01/04/2023
Date Insider Type Main position Quantity % Market Cap. Importance
3/4/25 A Buy

Chairman

860,735 4.6939%
1/27/25 A Buy

Chairman

45,000 0.2454%
1/9/25 A Buy

Chairman

30,000 0.1636%
Change 5-day change 1-year change 3-year change Capi.($)
+5.02%+8.37%+14.77%+28.91% 494M
-2.98%-3.24%+20.85%+31.84% 250B
-2.53%-5.16%+0.29%-0.58% 156B
-0.42%-2.42%-10.52%+39.53% 144B
-0.50%-4.35%-56.65%-18.36% 61.45B
-0.86%-0.40%+12.21%+19.78% 50.28B
+1.66%-1.55%-20.09%-20.26% 46.73B
-1.00%-3.36%+19.55%+53.45% 48.29B
+0.02%+1.26%-4.31%+40.76% 45.89B
-0.84%-1.47%+32.90%+64.08% 43.24B
Average +0.39%-1.77%+0.90%+23.91% 84.57B
Weighted average by Cap. -0.58%-2.77%+2.51%+23.31%

Financials

2026 *2027 *
Net sales 798M 83.6M 74.26M 69.52M 63M 118M 8.06B 120M 834M 324M 4.11B 314M 307M 13.19B 868M 90.93M 80.77M 75.61M 68.52M 128M 8.76B 130M 908M 353M 4.47B 341M 334M 14.34B
Net income 182M 19.11M 16.97M 15.89M 14.4M 26.96M 1.84B 27.38M 191M 74.15M 940M 71.72M 70.18M 3.01B 203M 21.25M 18.88M 17.67M 16.02M 29.98M 2.05B 30.45M 212M 82.48M 1.05B 79.77M 78.06M 3.35B
Net Debt -138M -14.4M -12.79M -11.97M -10.85M -20.31M -1.39B -20.63M -144M -55.87M -708M -54.03M -52.87M -2.27B -158M -16.6M -14.74M -13.8M -12.5M -23.41M -1.6B -23.78M -166M -64.4M -817M -62.29M -60.95M -2.62B
Projected Income Statement - Annual - Medistim ASA
Logo Medistim ASA
Medistim ASA is a Norway-based company engaged in the provision of medical equipment and technology. It develops, manufactures and distributes medical devices that measure blood flow and visualize atherosclerosis, and thereby help improve the outcome of cardiac and vascular surgery. The Company provides Transit Time Flow Measurement (TTFM) and ultrasound imaging to the global market to enable medical professionals to reduce risk and enhance quality of cardiac, vascular and transplant surgery. Medistim’s activities are divided into two business units: Own Products Category and Third-Party Products Category. Furthermore, the Company has several subsidiaries, including Medistim USA Inc, Medistim Norge AS and Medistim Japan KK.
Employees
159
Date Price Change Volume
06/10/26 NOK 272.00 +5.02% 90,428
05/10/26 NOK 259.00 +3.60% 24,613
02/10/26 NOK 250.00 -1.19% 11,420
01/10/26 NOK 253.00 0.00% 9,980
30/09/26 NOK 253.00 +0.40% 16,094
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Medistim ASA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
272.00NOK
Average target price
332.50NOK
Spread / Average Target
+22.24%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Medistim ASA
  1. Stock Market
  2. Stocks
  3. MEDI Stock